
Profitability, historical returns, and peer comparisons.
According to Pomdoctor Limited’s latest financial reports and current stock price. The company's current ROE is 79.79%. This represents a change of 207.49% compared to the average of 25.95% of the last 4 quarters.
The mean historical ROE of Pomdoctor Limited over the last ten years is 43.01%. The current 79.79% ROE has changed 85.53% with respect to the historical average. Over the past ten years (40 quarters), POM's ROE was at its highest in in the June 2026 quarter at 48.48%. The ROE was at its lowest in in the June 2024 quarter at 0%.
Average
43.01%
Median
10.19%
Minimum
6.33%
Maximum
139.55%
Discovering the peaks and valleys of Pomdoctor Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 639.31%
Maximum Annual ROE = 139.55%
Minimum Annual Increase = -88.01%
Minimum Annual ROE = 6.33%
| Year | ROE | Change |
|---|---|---|
| 2025 | 46.83% | 639.31% |
| 2024 | 6.33% | -7.64% |
| 2023 | 6.86% | 7.90% |
| 2022 | 6.36% | -37.62% |
| 2021 | 10.19% | -88.01% |
| 2020 | 84.95% | -39.13% |
The current ROE of Pomdoctor Limited (POM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
20.01%
5-year avg
15.31%
10-year avg
43.01%
Pomdoctor Limited’s ROE is greater than SI-BONE, Inc. (-8.23%), greater than Pacific Biosciences of California, Inc. (-4961.74%), greater than AirSculpt Technologies, Inc. (-12.52%), greater than Innovage Holding Corp. (-1.05%), greater than Orthofix Medical Inc. (-14.05%), greater than Anavex Life Sciences Corp. (-21.11%), greater than Erasca, Inc. (-80.43%), less than Aquestive Therapeutics, Inc. (243.68%), greater than Fulgent Genetics, Inc. (-7.87%), greater than CytomX Therapeutics, Inc. (-38.46%),
| Company | ROE | Market cap |
|---|---|---|
| -8.23% | $923.71M | |
| -4961.74% | $736.67M | |
| -12.52% | $121.48M | |
| -1.05% | $1.23B | |
| -14.05% | $360.16M | |
| -21.11% | $108.11M | |
| -80.43% | $4.91B | |
| 243.68% | $462.51M | |
| -7.87% | $529.39M | |
| -38.46% | $468.64M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pomdoctor Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pomdoctor Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Pomdoctor Limited's ROE?
How is the ROE calculated for Pomdoctor Limited (POM)?
What is the highest ROE for Pomdoctor Limited (POM)?
What is the 3-year average ROE for Pomdoctor Limited (POM)?
What is the 5-year average ROE for Pomdoctor Limited (POM)?
How does the current ROE for Pomdoctor Limited (POM) compare to its historical average?